57 related articles for article (PubMed ID: 16511519)
1. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
2. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y; Van den Bergh JM; Lion E; Anguille S; Roelandts VA; Van Acker HH; Heynderickx SD; Stein BM; Peeters M; Figdor CG; Van Tendeloo VF; de Vries IJ; Adema GJ; Berneman ZN; Smits EL
Cancer Immunol Immunother; 2015 Jul; 64(7):831-42. PubMed ID: 25863943
[TBL] [Abstract][Full Text] [Related]
3. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.
Schuurhuis DH; Lesterhuis WJ; Kramer M; Looman MG; van Hout-Kuijer M; Schreibelt G; Boullart AC; Aarntzen EH; Benitez-Ribas D; Figdor CG; Punt CJ; de Vries IJ; Adema GJ
Cancer Immunol Immunother; 2009 Jul; 58(7):1109-15. PubMed ID: 19018531
[TBL] [Abstract][Full Text] [Related]
4. Monophosphoryl lipid A plus IFNgamma maturation of dendritic cells induces antigen-specific CD8+ cytotoxic T cells with high cytolytic potential.
ten Brinke A; van Schijndel G; Visser R; de Gruijl TD; Zwaginga JJ; van Ham SM
Cancer Immunol Immunother; 2010 Aug; 59(8):1185-95. PubMed ID: 20336295
[TBL] [Abstract][Full Text] [Related]
5. Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.
Hobo W; Novobrantseva TI; Fredrix H; Wong J; Milstein S; Epstein-Barash H; Liu J; Schaap N; van der Voort R; Dolstra H
Cancer Immunol Immunother; 2013 Feb; 62(2):285-97. PubMed ID: 22903385
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.
Zhou Y; McEarchern JA; Howard E; Pestano G; Salgaller ML; Bosch ML
Cancer Immunol Immunother; 2003 Jul; 52(7):413-22. PubMed ID: 12835918
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?
Schaft N; Wellner V; Wohn C; Schuler G; Dörrie J
Cancer Immunol Immunother; 2013 Dec; 62(12):1769-80. PubMed ID: 24114143
[TBL] [Abstract][Full Text] [Related]
8. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer.
Seya T; Matsumoto M
Cancer Immunol Immunother; 2009 Aug; 58(8):1175-84. PubMed ID: 19184005
[TBL] [Abstract][Full Text] [Related]
9. Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.
Sauerer T; Albrecht L; Sievers NM; Gerer KF; Hoyer S; Dörrie J; Schaft N
Methods Mol Biol; 2024; 2786():219-235. PubMed ID: 38814397
[TBL] [Abstract][Full Text] [Related]
10. Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice.
Selmi A; Vascotto F; Kautz-Neu K; Türeci Ö; Sahin U; von Stebut E; Diken M; Kreiter S
Cancer Immunol Immunother; 2016 Sep; 65(9):1075-83. PubMed ID: 27422115
[TBL] [Abstract][Full Text] [Related]
11. An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8
de Mey W; Locy H; De Ridder K; De Schrijver P; Autaers D; Lakdimi A; Esprit A; Franceschini L; Thielemans K; Verdonck M; Breckpot K
Front Immunol; 2023; 14():1111523. PubMed ID: 36860873
[TBL] [Abstract][Full Text] [Related]
12. Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications.
Salah A; Wang H; Li Y; Ji M; Ou WB; Qi N; Wu Y
Front Cell Dev Biol; 2021; 9():686544. PubMed ID: 34262904
[TBL] [Abstract][Full Text] [Related]
13. An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.
Tomasicchio M; Semple L; Esmail A; Meldau R; Randall P; Pooran A; Davids M; Cairncross L; Anderson D; Downs J; Malherbe F; Novitzky N; Panieri E; Oelofse S; Londt R; Naiker T; Dheda K
Cancer Immunol Immunother; 2019 Jan; 68(1):71-83. PubMed ID: 30283982
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.
Van den Bergh JMJ; Smits ELJM; Versteven M; De Reu H; Berneman ZN; Van Tendeloo VFI; Lion E
J Immunol Res; 2017; 2017():1975902. PubMed ID: 28785596
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases.
Wilgenhof S; Corthals J; Van Nuffel AM; Benteyn D; Heirman C; Bonehill A; Thielemans K; Neyns B
Cancer Immunol Immunother; 2015 Mar; 64(3):381-8. PubMed ID: 25548092
[TBL] [Abstract][Full Text] [Related]
16. mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
Van Lint S; Heirman C; Thielemans K; Breckpot K
Hum Vaccin Immunother; 2013 Feb; 9(2):265-74. PubMed ID: 23291946
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.
Van Nuffel AM; Benteyn D; Wilgenhof S; Pierret L; Corthals J; Heirman C; van der Bruggen P; Coulie PG; Neyns B; Thielemans K; Bonehill A
Mol Ther; 2012 May; 20(5):1063-74. PubMed ID: 22371843
[TBL] [Abstract][Full Text] [Related]
18. A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice.
Creusot RJ; Chang P; Healey DG; Tcherepanova IY; Nicolette CA; Fathman CG
Mol Ther; 2010 Dec; 18(12):2112-20. PubMed ID: 20628358
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.
Breckpot K; Escors D
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):328-43. PubMed ID: 19857199
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
